Skip to main content
SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD. logo

SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 688163 ISIN · CNE1000059X8 LEI · 8368001TREMN2G5DDS70 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 335 across all filing types
Latest filing 2026-04-24 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688163

About SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD.

https://www.serum-china.com.cn/en/

Shanghai Serum Bio-Technology Co., Ltd. is a specialized biopharmaceutical enterprise focused on the research, development, and manufacturing of therapeutic biological products. The company primarily produces a range of antiserums and antitoxins, including specialized antivenoms for various snake species, tetanus antitoxins, and rabies immunoglobulins. Its product portfolio supports emergency medical care and infectious disease management. The organization maintains advanced production facilities compliant with Good Manufacturing Practice (GMP) standards to ensure the safety and efficacy of its biological treatments. By leveraging biotechnological innovation, the company serves clinical needs in healthcare sectors, providing critical life-saving interventions for envenomation and acute bacterial toxins.

Recent filings

Filing Released Lang Actions
赛伦生物：2025年度董事会审计委员会履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2025年度董事会审计委员会履职情况报告" which translates to "2025 Annual Report on the Board Audit Committee's Performance." It details the audit committee's activities, meetings, supervision of external and internal audits, review of financial reports, internal control assessments, and coordination with management and auditors. The content focuses on the audit committee's oversight and evaluation of the company's financial reporting and internal controls for the year 2025. It is not a full annual report (10-K) but a specific report on audit committee activities and audit-related matters. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and related evaluations. The document is 2575 characters long, which is relatively short but contains substantive content about audit committee work rather than just an announcement or certification. Therefore, the best classification is AR with high confidence. FY 2025
2026-04-24 Chinese
赛伦生物：董事会关于独立董事独立性自查情况的专项报告
Board/Management Information Classification · 95% confidence The document is a special report from the board of directors regarding the independence of the company's independent directors. It references regulatory guidelines related to independent directors and confirms their independence and qualifications. The content is focused on governance and compliance with director independence rules, rather than financial results, audit opinions, or shareholder voting outcomes. The document length is short (478 characters), and it is a formal report on board/management matters, specifically about director independence. This fits best under Board/Management Information (MANG), which covers announcements related to board or senior management matters, including director independence assessments.
2026-04-24 Chinese
方正证券承销保荐有限责任公司关于上海赛伦生物技术股份有限公司2025年度募集资金存放、管理与实际使用情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed special audit opinion report by 方正证券承销保荐有限责任公司 (a sponsoring institution) on the 2025 annual fundraising funds deposit, management, and actual usage of Shanghai Sailun Biotechnology Co., Ltd. It includes detailed financial figures about the fundraising amount, usage, balance, management, and investment projects. It also contains the auditor's conclusion and the sponsor's verification opinion. The document references regulatory rules related to fundraising and securities issuance, and it is a standalone audit-type report focusing on the use and management of raised funds for the year 2025. It is not a full annual report (10-K), nor an earnings release or interim report. It is not a simple announcement or certification but a substantive audit opinion on fundraising usage. Therefore, it fits best under the category of Audit Report / Information (AR). FY 2025
2026-04-24 Chinese
赛伦生物：2025年度独立董事述职报告（傅以尚）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2025 from Shanghai Sailun Biotechnology Co., Ltd. It details the independent director's duties, attendance at board and committee meetings, communication with auditors, oversight of financial reports, and other governance activities during the year. The content focuses on the independent director's work and evaluation rather than presenting full financial statements or audit results. The document length is 3782 characters, which is relatively short and more consistent with a report or statement rather than a full annual report or audit report. It is not a certification or a brief announcement but a detailed narrative of the independent director's annual work. This type of document fits best under the category of Board/Management Information (MANG), as it relates to governance and management oversight activities by a board member. It is not an Annual Report (10-K), Audit Report (AR), or Regulatory Filing (RNS). Therefore, the classification is MANG with high confidence.
2026-04-24 Chinese
赛伦生物：2025年度审计委员会对会计师事务所履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from the Board Audit Committee regarding the supervision of the accounting firm Tianzhi International for the fiscal year 2025. It discusses the auditor's qualifications, audit procedures, meetings held, and the audit committee's evaluation of the auditor's performance and independence. The document references the 2025 annual audit and the audit report but does not contain the full annual report or financial statements itself. It is a standalone audit-related report focusing on the audit firm's supervision and performance, which fits the definition of an Audit Report / Information (AR). The document length is 2646 characters, which is relatively short but contains substantive content about audit supervision rather than just an announcement or certification. Therefore, it is classified as AR with high confidence. FY 2025
2026-04-24 Chinese
赛伦生物：2025年年度报告
Annual Report Classification · 100% confidence The document is titled "上海赛伦生物技术股份有限公司2025年年度报告" which translates to "Shanghai Serum Bio-Technology Co., Ltd. 2025 Annual Report." It contains detailed financial data for the year 2025, including revenue, profit, net assets, and quarterly breakdowns. It also includes management discussion and analysis, company overview, business model, industry analysis, and detailed product descriptions. The document is extensive (15,000 characters) and includes audited financial statements and auditor's opinion. The presence of comprehensive financial data, management discussion, and company overview confirms this is a full annual report covering the company's yearly activities and financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2025
2026-04-24 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.